BA
MRTX

Bridgewater Associates’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bridgewater Associates’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,238
Closed -$328K – 926
2022
Q4 		$328K Buy
+7,238
New +$328K ﹤0.01% 762
2022
Q3 		– Sell
-3,714
Closed -$249K – 1040
2022
Q2 		$249K Buy
+3,714
New +$249K ﹤0.01% 959